Literature DB >> 29380079

Machine Learning EEG to Predict Cognitive Functioning and Processing Speed Over a 2-Year Period in Multiple Sclerosis Patients and Controls.

Hanni Kiiski1, Lee Jollans1, Seán Ó Donnchadha2, Hugh Nolan3, Róisín Lonergan4, Siobhán Kelly4, Marie Claire O'Brien2, Katie Kinsella4, Jessica Bramham2, Teresa Burke2,5, Michael Hutchinson4, Niall Tubridy4, Richard B Reilly3,6,7, Robert Whelan8,9.   

Abstract

Event-related potentials (ERPs) show promise to be objective indicators of cognitive functioning. The aim of the study was to examine if ERPs recorded during an oddball task would predict cognitive functioning and information processing speed in Multiple Sclerosis (MS) patients and controls at the individual level. Seventy-eight participants (35 MS patients, 43 healthy age-matched controls) completed visual and auditory 2- and 3-stimulus oddball tasks with 128-channel EEG, and a neuropsychological battery, at baseline (month 0) and at Months 13 and 26. ERPs from 0 to 700 ms and across the whole scalp were transformed into 1728 individual spatio-temporal datapoints per participant. A machine learning method that included penalized linear regression used the entire spatio-temporal ERP to predict composite scores of both cognitive functioning and processing speed at baseline (month 0), and months 13 and 26. The results showed ERPs during the visual oddball tasks could predict cognitive functioning and information processing speed at baseline and a year later in a sample of MS patients and healthy controls. In contrast, ERPs during auditory tasks were not predictive of cognitive performance. These objective neurophysiological indicators of cognitive functioning and processing speed, and machine learning methods that can interrogate high-dimensional data, show promise in outcome prediction.

Entities:  

Keywords:  Cognitive function; Electroencephalography; Longitudinal; Machine learning; Multiple sclerosis; Oddball paradigm

Mesh:

Year:  2018        PMID: 29380079     DOI: 10.1007/s10548-018-0620-4

Source DB:  PubMed          Journal:  Brain Topogr        ISSN: 0896-0267            Impact factor:   3.020


  7 in total

Review 1.  A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases.

Authors:  I S Stafford; M Kellermann; E Mossotto; R M Beattie; B D MacArthur; S Ennis
Journal:  NPJ Digit Med       Date:  2020-03-09

Review 2.  Machine Learning Use for Prognostic Purposes in Multiple Sclerosis.

Authors:  Ruggiero Seccia; Silvia Romano; Marco Salvetti; Andrea Crisanti; Laura Palagi; Francesca Grassi
Journal:  Life (Basel)       Date:  2021-02-05

3.  Multiple sclerosis diagnosis and phenotype identification by multivariate classification of in vivo frontal cortex metabolite profiles.

Authors:  Kelley M Swanberg; Abhinav V Kurada; Hetty Prinsen; Christoph Juchem
Journal:  Sci Rep       Date:  2022-08-16       Impact factor: 4.996

4.  The role of machine learning in developing non-magnetic resonance imaging based biomarkers for multiple sclerosis: a systematic review.

Authors:  Md Zakir Hossain; Elena Daskalaki; Anne Brüstle; Jane Desborough; Christian J Lueck; Hanna Suominen
Journal:  BMC Med Inform Decis Mak       Date:  2022-09-15       Impact factor: 3.298

5.  Deficits in Early Sensory and Cognitive Processing Are Related to Phase and Nonphase EEG Activity in Multiple Sclerosis Patients.

Authors:  Esteban Sarrias-Arrabal; Sara Eichau; Alejandro Galvao-Carmona; Elvira Domínguez; Guillermo Izquierdo; Manuel Vázquez-Marrufo
Journal:  Brain Sci       Date:  2021-05-13

Review 6.  A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases.

Authors:  I S Stafford; M Kellermann; E Mossotto; R M Beattie; B D MacArthur; S Ennis
Journal:  NPJ Digit Med       Date:  2020-03-09

Review 7.  Towards Multimodal Machine Learning Prediction of Individual Cognitive Evolution in Multiple Sclerosis.

Authors:  Stijn Denissen; Oliver Y Chén; Johan De Mey; Maarten De Vos; Jeroen Van Schependom; Diana Maria Sima; Guy Nagels
Journal:  J Pers Med       Date:  2021-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.